Code | 5874D | ||||||||||
MA number | 44/0254/20-S | ||||||||||
Product Form: | con inf 1x6 ml/60 mg (liek.inj.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | EVER Valinject GmbH, Austria | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 26.11.2020 |
Validity: | 26.11.2025 |
SPC: | SPC_Cabazitaxel EVER Pharma 10 mg_ml koncentrát na infúzny roztok_08.2023.pdf |
PIL: | PIL_Cabazitaxel EVER Pharma 10 mg_ml koncentrát na infúzny roztok_10.2023.pdf |
Safety feature | Yes |
Data update: | 02.08.2023 |